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Methods and Results. Sixty-seven patients in whom plaque material was obtained compose the study population. A total of 73 lesions from both coronary (n=38) and peripheral (n=35) arteries of primary (n=50) and restenotic origin (n=23) were studied. Successful cultivation was significantly (p<0.001) dependent on the quantity of plaque material submitted. Fifty-five percent of patients in whom atherectomy specimens were removed from coronary lesions yielded an adequate SMC population in comparison to 89% of those from peripheral arteries (p<0.01). Cultivation was not dependent on the age and sex of patients, lesion origin, risk factors, medications, or incidence of unstable angina. In an attempt to quantify SMC activity, migratory velocity was measured with a computer-assisted motion analysis system. SMC migratory velocity was found to be significantly (p<0.001) greater in restenotic than in primary plaque material. This finding was confirmed for both coronary and peripheral lesions.
Conclusions. Our data suggest that elevated SMC migratory activity may be an important mechanism in the development of restenotic lesions. (Circulation 1992;85:554-564) T ranslocation of cells is an essential biological mechanism involved in heterogeneous and complex processes such as fetal development, wound healing, inflammation, and malignant invasion.1-9 In atherogenesis and restenosis formation, mounting evidence supports the concept that migration of smooth muscle cells (SMCs) across the vascular wall is important in the initiation of myointimal thickening and plaque development.10-13 Grunwald and Haudenschild14 demonstrated that explants obtained from in vivo balloon-injured rat aorta exhibited an increase in SMC migration and proliferation in vitro compared with explants of noninjured vascular wall. In addition, Schwartz and coworkers13'15 demonstrated in a rat carotid artery model that in response to injury, the resultant intimal thickening comprises SMCs, 90% of which are of medial origin. Furthermore, the same researchers differentiated between migration and migration plus subsequent proliferation as principal mechanisms of atherogenesis.
This report discusses cell cultures of human plaque tissue obtained from diseased coronary and peripheral arteries treated with percutaneous atherectomy. In this model, migratory velocity of human SMCs was quantified with a computer-assisted analysis system. Special emphasis was placed on comparison of primary and restenotic SMC migratory activities. The results obtained indicate that increased in vitro SMC migratory activity is associated with human restenosis formation.
Methods

Patient Population
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Cell Culture Technique
The explant technique used for cell cultivation of coronary and peripheral arterial plaque material was essentially as described previously. 21, 22 Briefly, atherectomy specimens were immediately rinsed with 0.9% saline and placed in cell culture medium com-posed of Ham F12 (Biochrom, Berlin, FRG) and Waymouth's MB 752/1 (GIBCO BRL, Eggenstein, FRG) (1:1, vol:vol), buffered with 10 mM HEPES, and supplemented with 15% fetal bovine serum (charge 30Q9487X; GIBCO, Eggenstein, FRG) and 0.1% tobramycin. The larger amount of peripheral material allowed the use of a 25-cm2 plastic cell culture flask (Costar; Tecnomara, Fernwald, FRG) with 5 ml of cell culture medium. Because of the limited amount of material available from coronary lesions, a miniaturized cell culture system limited to 1 ml of cell culture medium over an area of 3.8 cm2 (2.2-cm diameter, 12 
atmosphere at 37°C with 5% CO2. Outgrowth time was determined as suggested by Bierman.23 
Identification of SMCs by
Immunofluorescence Microscopy For immunological identification and characterization, cells were grown on round glass coverslips and fixed in methanol for 5 minutes, and indirect immunofluorescence was carried out as previously described.22'24 Primary monoclonal antibodies were specific for smooth muscle a-actin (Boehringer Mannheim, FRG) and factor VIII-related antigen (Calbiochem, Frankfurt, FRG). Tetrareodaminyl-isothiocyanate (TRITC) -and fluorescein-isothyocyanate (FITC) -labeled secondary antibodies were purchased from Dakopatts, Glostrup, Denmark. Nuclear counterstaining was performed with 4',6-diamidino-2-phenylindole-dihydrochloride (DAPI; Serva Feinbiochemika, Heidelberg, FRG) at a concentration of 0.1 ,ug/ml in phosphate-buffered saline for 20 minutes at 37°C.
Analysis of SMC Motion
SMCs were cultivated until they reached a subconfluent density of 2,000-5,000 cells/cm2. As many as 10 randomly selected SMCs per dish were monitored for 60 seconds every 30 minutes during a period of at least 5 hours with an inverted phase contrast microscope (IMT2; Olympus, Hamburg, FRG). The images were obtained with the use of a videocamera and stored on a U-matic video recording system (V0-5800 PS; Sony, Muenchen, FRG). A surrounding incubation chamber (Certomat H; Braun Melsungen, FRG) kept the temperature constant at 37°C. A minimum of 10 subsequent records per chosen microscopic field (magnification, x400) were used for analysis of SMC translocation. With the aid of a computer-assisted motion analyzer, the cellular out-4 (Ath) 3 (PTA) 3 (Ath) 5 (Ath) 5 (Ath) 3 (PTA) 3 (PTA) 6 (Ath) FIGURE 1. Photomicrograph of representative example of human smooth muscle cells cultivatedfrom coronary restenotic plaque after 12 days in culture (lesion 25). Bar, 100 pin. line was drawn, and the centroid was positioned. Cell movement was characterized by tracking the centroid of each cell for at least 5 hours. Angular change of a motile SMC was calculated from the deviation of the individual path covered during the preceding time interval. Migration velocity was determined from the distance of centroid translocation covered after a period of 30 minutes. Analysis of SMC migratory velocity was performed with a computerized system previously described.25 -27 
Statistical Analysis
Analyses of success in culturing SMCs between groups of patients and between number of plaque specimens, plaque weight, patient age, sex, lesion origin, and stenotic degree before and after intervention were performed with the Mann-Whitney U test. Group differences in cultivation success, outgrowth period, risk factors, medications, and clinical condition of unstable angina were compared by x2 tests for categorical variables. All calculated probability values were twotailed and corrected for ties. All values ofp<O.05 were considered to indicate significance. Group data are presented as mean±SD or ±SEM, as indicated.
Results
This report systematically investigates the feasibility of cultivating human coronary as well as peripheral atherectomy specimens in relation to patient characteristics and clinical data. Our intention was to characterize activity of cultured SMCs, which succeeded in establishing SMC in vitro migratory activity as a quantified parameter. A motion analysis system measuring migratory velocity was used with special regard to the question of whether SMC migratory activity of primary lesions differs from that of restenotic lesions.
Morphology and Identification of Human Plaque Cells
Cultured cells from coronary and peripheral lesions of both primary and restenotic origin exhibited comparable light microscopic morphology of spindleshaped or polygonal appearance. Figure 1 is a typical example of cultivated plaque cells from a restenotic coronary lesion (lesion 25). All cells showed focal membrane ruffling and migratory activity regardless of coronary or peripheral origin or presence of restenosis. The majority of cultivated cells exhibited many stress fibers extending to lamellipodia ( Figure  1 ). By use of immunofluorescent techniques, smooth muscle a-actin was observed in 80-90% of all cultured cells, confirming their identity as SMCs. A representative pattern of the a-actin cytoskeleton of a population of coronary SMCs is depicted in Figure  2 . Of interest, endothelial cells were not found in any FIGURE 2. Photomicrograph ofindirect immunofluorescence microscopy ofsmooth muscle cells fiom a primary coronary plaque (lesion 2). Positive reaction with antibodies against smooth muscle a-actin and counterstaining ofnuclei with DAPI are seen. Bar, 10 gin. cultured specimen from coronary or peripheral lesions as determined by staining with monoclonal antibodies to factor VIII-related antigen. SMC Motion Analysis Locomotion analysis showed a randomly distributed pattern of angular changes between 00 and 1800 for SMCs derived from all four subgroups. In Figure  3 , the tracks covered by three different coronary SMCs from a restenotic lesion (lesion 25) are illustrated; the positions of moving cells were marked by their centroids after each 30-minute period. During the migratory process, pronounced alterations of cellular shape were observed due to outpouching of lamellipodia. Pseudopodia protrusion is a prominent feature of actively motile cells in vitro.28 For SMCs derived from primary as well as from restenotic lesions, no significant dependency on serum concentration was found in the range of 1-15% fetal bovine serum. This finding indicates that in vitro SMC migratory activity is a process unrelated to SMC proliferation, which was shown to be serum dependent.2229 In addition, SMCs did not show statistically different values of migration velocity over a period of up to 7 days of cultivation.
SMC Migratory Activity -Restenotic Versus Primary Lesions
SMCs of restenotic origin migrated markedly faster than those from primary lesions. Table 6 is a summary of migratory activity measured for each experimental sample. The overall migratory veloci- ties of SMCs from primary lesions in both coronary and peripheral arteries were similar (group A:
19.4±5.1 ,um/hr, n=7; group C: 21.1±2.5 gm/hr, n = 12). In contrast, migratory velocities of coronary and peripheral SMCs of restenotic origin were found to be distinctly increased (group B: 46.2±3.6 ,um/hr, n=5; group D: 48.0±3.0 ,um/hr, n=6). Figure 4 is a summary of SMC migration velocities of all four subgroups, thereby emphasizing the highly significant differences between primary and restenotic lesions of both coronary and peripheral arteries (groups A plus C versus groups B plus D, p<0.001; group A versus group B, p<0.01; group C versus group D, p<0.001). These data clearly indicate that increased in vitro migratory activity is a basic biological feature of restenotic smooth muscle cells irrespective of their vascular segments.
Cultivation ofAtherectomy Specimens as Related to Clinical Variables
First, the ability to culture human atheromatous plaque cells depended significantly (p<0.001) on the amount of plaque material submitted (number of specimens as well as wet weight) ( Table 5 ). When comparing coronary with peripheral lesions (groups A plus B versus groups C plus D), successful cultivation occurred in 21 of 38 coronary cases (55%); this was significantly less (p <0.01) than in 31 of 35 peripheral cases (87%). Compared with peripheral material with an average wet weight of 95 ± 74 mg per lesion (n =35), coronary atherectomy tissue was characterized by significantly reduced wet weight (19±14 mg per lesion, n=38) and number of specimens removed (p<0.001). In addition, time span until outgrowth was longer in the coronary groups than in the corresponding peripheral groups (A versus C, p<0.01; B versus D, p<0.05). First outgrowth was seen after a mean±SEM period of 13.0±6.9 days for group A (n=12) and 11.2±9.8 days for group B (n =9). Peripheral outgrowth required an average of 7.9±3.4 days for group C (n=22) and 8.4±3.6 days for group D (n=9).
Second, when comparing restenotic with primary lesions, no significant differences were found within the coronary (B versus A) or the peripheral groups (D versus C) in the amount of plaque material removed (for mean wet weights of groups A through D, see Table 5 ) and the observed outgrowth periods (see above).
Third, successful cultivation as well as SMC migratory activity were not dependent on patient characteristics and clinical data. Specifically, these determinants were not dependent on age and sex of patients, stenotic degree before and after intervention, or lesion origin for primary versus restenotic lesions. In addition, no significant correlation was seen with regard to incidence of unstable angina or presence and number of risk factors or medications (Tables 3 and 4 ).
Discussion This report describes the successful cultivation of human plaque cells from percutaneously removed coronary atherectomy specimens compared with those obtained from peripheral lesions. In the present study, we show that the vast majority (80-90%) of outgrowing cells from percutaneously removed coronary plaques are SMCs, which agrees with previous findings of percutaneously atherectomized or necropsy tissue removed from high-grade lesions in peripheral arteries.21,22,29,30 Importantly, endothelial cells were not observed in cultured coronary atherectomy specimens.
Coronary atherectomy treatment of our patients provided plaque material of wet weight averaging 19 + 14 mg per lesion. Thus, a small amount of plaque tissue was retrieved by the coronary Atherocath, which is in agreement with recent experience.20 As a consequence, we established the miniaturized cell culture system described using the explant technique. Attempts to disaggregate coronary specimens with enzymes did not result in adequate SMC cultivation. By the choice of the explant technique, outgrowing SMCs were observed in 55% of explanted coronary samples. In the compared series of peripheral specimens, a success rate of 87% was shown. This finding is due to the restricted amount of plaque material available through percutaneous coronary atherectomy. Also, the longer outgrowth periods for coronary explants may be attributed to the smaller amount of plaque tissue retrieved. Statistical analysis of a spectrum of patient characteristics and qualitative and quantitative aspects of clinical data (Tables 1-4) showed no relation with cell culture success. Interestingly, incidence of unstable angina did not influence the outcome of plaque cultivation, although frequency of thrombus formation is much higher among patients with unstable angina,31 and platelet aggregation may induce local growth factor delivery.
The main concern of the present study was to solve the problem of how to characterize SMC activity. To this end, our interest focused on SMC proliferative and migratory activities, as these determinants are recognized as key events in atherogenesis and re-stenosis formation.'0, 32, 33 In proliferation studies, growth curves describe the replication rate of single cells for which enzymatic isolation and a threshold amount of plaque tissue are prerequisites. This methodical approach, however, could not be applied to our experimental conditions because enzymatic disaggregation of coronary atherectomy specimens, which are typically characterized by small tissue volume, did not result in adequate SMC cultivation. Even with the increased quantity of atherectomy specimens from peripheral lesions, further subcultivation was necessary in several cases to enlarge SMC number for the calculation of SMC population-doubling rates. 22 In addition to proliferation, migration of SMCs provides another important mechanism involved in plaque formation. Which experimental design could be applied for the characterization of SMC migratory activity against the discussed background of limited availability of plaque tissue and cultured cells? The standardized motion analysis system described in the present report provided the ability to quantify SMC migratory activity, even in the presence of low numbers of SMCs, such as those obtained from coronary lesions. As an advantage of the experimental concept introduced herein, migrating SMCs were randomly selected and directly and continuously monitored without mechanically or chemically altering the milieu,34'35 as induced by enzymatic disintegration of the substrate. Chemotactic assays with the Boyden chamber,36'37 imitating directional migration as it is postulated to occur in vivo from the media to the intima,1013 could not be performed because enzymatic disaggregation of coronary specimens did not yield an adequate SMC number.
Increased Migratory Activity of Restenotic SMCs From Coronary and Peripheral Lesions
The main result of the present study is a significant difference in migratory velocity of SMCs cultured from restenotic versus primary lesions obtained from coronary and peripheral vessels ( Table 6 and Figure  4 ). Cells of restenotic origin had migratory velocities averaging 2.3-fold greater than that of cells from primary lesions (p<0.001). This distinct feature of restenotic SMCs was equally observed in seven lesions initially balloon dilated as well as in four lesions previously treated with atherectomy (Tables 1, 2, and 6). Our data suggest that increased SMC migratory activity is a basic biological process in human restenosis formation regardless of the treated vascular segment or choice of initial instrumentation, although the explanation for this phenomenon remains unknown. Bell and Madri38 suggested alterations in cytoskeletal components, modulation of cell matrix receptors, and changes in the synthetic profile of the migrating cell as possible explanations for different migratory activities. Koyama and coworkers39 subcultivated animal SMCs and isolated an SMC-derived migration factor distinct from platelet-derived growth factor, fibronectin, and several macrophagederived migratory factors. Fingerle et all' concluded that after balloon catheter injury of rat carotid arteries, growth factor release of platelets plays a minor role in promoting medial proliferation but is important in stimulation of SMC migration into the intima. Another explanation is that highly activated SMCs from restenotic lesions may stimulate their own growth in an autocrine manner. 22, 40, 41 Although growth factors may be important in the genesis of restenosis through their effect on SMCs, the growth factors responsible and the mechanism in which Increased SMC in vitro migratory activity is a common finding for restenotic versus primary coronary and peripheral plaques. In addition, elevated SMC proliferation rates have been reported for restenotic lesions when cultured from plaque material obtained by atherectomy of coronary and peripheral arteries when plaque material was removed at bypass graft surgery.22'44 These results suggest that there is a general phenomenon in which SMC migra-tory and proliferative activities are increased in human restenosis. Despite this concordant increase in proliferative and migratory SMC activities for restenotic lesions, our data indicate that SMC migration is independent of proliferation. In vitro migratory activities of SMCs originating from restenotic or primary lesions were not influenced by serum concentrations of 1-15%. In contrast, a marked serum concentration dependency was noted for proliferation of cultivated human SMCs from peripheral atherectomy specimens. 22 Our cell migration data agree with those of Thorgeirsson et al,12 who did not observe an effect of serum concentrations of as much as 10% when evaluating human venous SMC migratory activity for 6 days. Bell and Madri45 used a Teflon fence migration assay with bovine aortic SMCs and also proved that changes in migration kinetics were independent of associated changes in SMC proliferation. Together, these data indicate that migratory activity of vascular SMCs represents an activity parameter independent of proliferative processes.
Possible Clinical Application
In vitro models as reported herein may help to preselect individualized therapy to reduce restenosis or retard primary atherosclerosis, despite reservations in applying in vitro data to the clinical situation. Percutaneously obtained plaque material from an individual patient may be cultured to obtain a colony of SMCs on whose activity various agents may be tested. The most effective agent or drug may then be administered systemically or applied locally with the use of a perforated balloon catheter or an endovascular stent. 46 
